Leiden University Scholarly Publications

Your Search

Enabled Filters

  • (-) = Bradley, J.D.

Search results

  • RSS Feed
(1 - 6 of 6)
Is radiographic progression in modern rheumatoid arthritis trials still a robust outcome? Experience from tofacitinib clinical trials
Landewe, R.B.M.; Connell, C.A.; Bradley, J.D.; Wilkinson, B.; Gruben, D.; Strengholt, S.; Heijde, D. van der 2016
Is radiographic progression in modern rheumatoid arthritis trials still a robust outcome? Experience from tofacitinib clinical trials
Article / Letter to editor
metadata only
Comparing the effects of tofacitinib, methotrexate and the combination, on bone marrow oedema, synovitis and bone erosion in methotrexate-naive, early active rheumatoid arthritis: results of an exploratory randomised MRI study incorporating semiquantitati
Conaghan, P.G.; Ostergaard, M.; Bowes, M.A.; Wu, C.Y.; Fuerst, T.; Heijde, D. van der; ... ; Wilkinson, B. 2016
Comparing the effects of tofacitinib, methotrexate and the combination, on bone marrow oedema, synovitis and bone erosion in methotrexate-naive, early active rheumatoid arthritis: results of an exploratory randomised MRI study incorporating semiquantitative and quantitative techniques
Article / Letter to editor
metadata only
Effects of Tofacitinib on Bone Marrow Edema, Synovitis, and Erosive Damage in Methotrexate-Naive Patients with Early Active Rheumatoid Arthritis (Duration <= 2 Years): Results of an Exploratory Phase 2 MRI Study
Conaghan, P.G.; Ostergaard, M.; Wu, C.; Heijde, D. van der; Irazoque-Palazuelos, F.; Hrycaj, P.; ... ; Wilkinson, B. 2014
Effects of Tofacitinib on Bone Marrow Edema, Synovitis, and Erosive Damage in Methotrexate-Naive Patients with Early Active Rheumatoid Arthritis (Duration <= 2 Years): Results of an Exploratory Phase 2 MRI Study
Article / Letter to editor
metadata only
Tofacitinib (CP-690,550) in patients with rheumatoid arthritis receiving methotrexate: Twelve-month data from a twenty-fourmonth phase III randomized radiographic study
Heijde, D. van der; Tanaka, Y.; Fleischmann, R.; Keystone, E.; Kremer, J.; Zerbini, C.; ... ; ORAL Scan Investigators 2013
Tofacitinib (CP-690,550) in patients with rheumatoid arthritis receiving methotrexate: Twelve-month data from a twenty-fourmonth phase III randomized radiographic study
Article / Letter to editor
metadata only
Effects of Tofacitinib On Patient-Reported Outcomes in Patients with Active Rheumatoid Arthritis Receiving Stable-Dose Methotrexate: Results of Two Phase 3 Studies
Burmester, G.R.; Heijde, D. van der; Strand, V.; Zerbini, C.A.F.; Connell, C.A.; Mebus, C.A.; ... ; Wallenstein, G. 2012
Effects of Tofacitinib On Patient-Reported Outcomes in Patients with Active Rheumatoid Arthritis Receiving Stable-Dose Methotrexate: Results of Two Phase 3 Studies
Article / Letter to editor
metadata only
Tofacitinib (CP-690,550), An Oral Janus Kinase Inhibitor, in Combination with Methotrexate Reduced the Progression of Structural Damage in Patients with Rheumatoid Arthritis: a 24-Month Phase 3 Study
Heijde, D. van der; Tanaka, Y.; Fleischmann, R.; Keystone, E.C.; Kremer, J.M.; Zerbini, C.A.F.; ... ; ORAL Scan Investigators 2011
Tofacitinib (CP-690,550), An Oral Janus Kinase Inhibitor, in Combination with Methotrexate Reduced the Progression of Structural Damage in Patients with Rheumatoid Arthritis: a 24-Month Phase 3 Study
Article / Letter to editor
metadata only